Lev Gerlovin is speaking during the summit on “Adopting New Strategies to Support Cell & Gene Therapy Development.”
For more information on this event, click here.
Rare Disease: A year in review
As more investments have been made in developing and commercializing treatments for rare diseases, the experience and expertise of our CRA teams have grown....